Yixuan Wang

2.1k total citations · 1 hit paper
36 papers, 1.5k citations indexed

About

Yixuan Wang is a scholar working on Infectious Diseases, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Yixuan Wang has authored 36 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 11 papers in Cardiology and Cardiovascular Medicine and 5 papers in Molecular Biology. Recurrent topics in Yixuan Wang's work include Viral Infections and Immunology Research (5 papers), COVID-19 Clinical Research Studies (4 papers) and Animal Virus Infections Studies (4 papers). Yixuan Wang is often cited by papers focused on Viral Infections and Immunology Research (5 papers), COVID-19 Clinical Research Studies (4 papers) and Animal Virus Infections Studies (4 papers). Yixuan Wang collaborates with scholars based in China, United States and France. Yixuan Wang's co-authors include Yan Chen, Yuyi Wang, Qingsong Qin, Perla B. Balbuena, Jiaguo Liu, Yun Chen, Hongxu Du, Ke Ming, Jingjing Yang and Fangke Yao and has published in prestigious journals such as Journal of Medicinal Chemistry, Carbohydrate Polymers and Molecules.

In The Last Decade

Yixuan Wang

33 papers receiving 1.4k citations

Hit Papers

Unique epidemiological and clinical features of the emerg... 2020 2026 2022 2024 2020 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yixuan Wang China 12 658 235 210 185 153 36 1.5k
Synat Keam Australia 8 493 0.7× 195 0.8× 170 0.8× 200 1.1× 157 1.0× 14 1.2k
Maryam Taghdir Iran 17 499 0.8× 206 0.9× 250 1.2× 184 1.0× 168 1.1× 54 1.4k
Jinlyu Sun China 13 635 1.0× 210 0.9× 171 0.8× 165 0.9× 106 0.7× 51 1.5k
Zhengqi Tan United States 10 476 0.7× 127 0.5× 246 1.2× 216 1.2× 173 1.1× 18 1.4k
Naoya Itoh Japan 13 444 0.7× 142 0.6× 163 0.8× 169 0.9× 113 0.7× 83 1.5k
Aleksandra Marinkovic Nigeria 9 801 1.2× 306 1.3× 161 0.8× 190 1.0× 194 1.3× 31 1.4k
Chuku Okorie Nigeria 10 803 1.2× 309 1.3× 159 0.8× 231 1.2× 202 1.3× 40 1.7k
Giulio Viceconte Italy 11 665 1.0× 180 0.8× 181 0.9× 92 0.5× 115 0.8× 40 1.1k
Fujun Peng China 8 476 0.7× 146 0.6× 170 0.8× 152 0.8× 99 0.6× 22 1.2k
Jasmine Mangat Nigeria 5 685 1.0× 270 1.1× 145 0.7× 171 0.9× 190 1.2× 8 1.1k

Countries citing papers authored by Yixuan Wang

Since Specialization
Citations

This map shows the geographic impact of Yixuan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yixuan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yixuan Wang more than expected).

Fields of papers citing papers by Yixuan Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yixuan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yixuan Wang. The network helps show where Yixuan Wang may publish in the future.

Co-authorship network of co-authors of Yixuan Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yixuan Wang. A scholar is included among the top collaborators of Yixuan Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yixuan Wang. Yixuan Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sonani, Ravi R., Yangyang Wang, Zhao Chen, et al.. (2025). A type IV pili-mediated mutualism between two co-resident temperate archaeal viruses and their host. Cell Reports. 44(7). 115873–115873. 1 indexed citations
4.
Lin, Qing, Huimin Fan, Yixuan Wang, et al.. (2024). BIC/FTC/TAF Benefits People Living With HIV After Omicron Breakthrough Infection in Shortening Duration of Symptoms, Enhancing Specific Immune Response and Increasing Total CD4 Cells. Journal of Medical Virology. 96(11). e70036–e70036. 1 indexed citations
5.
Wang, Yixuan, et al.. (2024). Dietary flavonoid intake is negatively associated with accelerating aging: an American population-based cross-sectional study. Nutrition Journal. 23(1). 158–158. 1 indexed citations
6.
Chen, Jiaxin, et al.. (2024). Sorbaria sorbifolia flavonoid derivative induces mitochondrial apoptosis in human hepatoma cells through Bclaf1. Frontiers in Pharmacology. 15. 1459520–1459520. 1 indexed citations
8.
Wang, Yixuan, et al.. (2023). Sequence and directivity in cardiac muscle injury of COVID-19 patients: an observational study. Frontiers in Cardiovascular Medicine. 10. 1260971–1260971. 1 indexed citations
9.
10.
Chen, Shuai, Yixuan Wang, Fenghua Ding, et al.. (2022). Serum apolipoprotein A-IV levels are associated with flow-mediated dilation in patients with type 2 diabetes mellitus. BMC Cardiovascular Disorders. 22(1). 446–446. 2 indexed citations
11.
Tan, Jiali, Yixuan Wang, Jinhua Chen, et al.. (2020). 2-((4-Arylpiperazin-1-yl)methyl)benzonitrile Derivatives as Orally Available Inhibitors of Hepatitis C Virus with a Novel Mechanism of Action. Journal of Medicinal Chemistry. 63(11). 5972–5989. 8 indexed citations
12.
Wang, Yixuan, et al.. (2020). Design, synthesis, and biological evaluation of 2,6,7-substituted pyrrolo[2,3-d]pyrimidines as cyclin dependent kinase inhibitor in pancreatic cancer cells. Bioorganic & Medicinal Chemistry Letters. 33. 127725–127725. 14 indexed citations
13.
Wang, Yixuan, Yuyi Wang, Yan Chen, & Qingsong Qin. (2020). Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID‐19) implicate special control measures. Journal of Medical Virology. 92(6). 568–576. 1070 indexed citations breakdown →
14.
Wang, Yixuan, et al.. (2019). Design, synthesis, and evaluation of novel 4-amino-2-(4-benzylpiperazin-1-yl)methylbenzonitrile compounds as Zika inhibitors. Bioorganic & Medicinal Chemistry Letters. 30(4). 126906–126906. 9 indexed citations
15.
Chen, Yun, Hongxu Du, Shuaibing Zhang, et al.. (2017). RAW REHMANNIA RADIX POLYSACCHARIDE CAN EFFECTIVELY RELEASE PEROXIDATIVE INJURY INDUCED BY DUCK HEPATITIS A VIRUS. African Journal of Traditional Complementary and Alternative Medicines. 14(4). 8–21. 12 indexed citations
16.
Ji, Lei, et al.. (2017). Successful treatment of acute renal infarction arising from left atrial myxoma and atrial fibrillation: A case report. Experimental and Therapeutic Medicine. 14(3). 2633–2636. 1 indexed citations
17.
Ming, Ke, Yun Chen, Fangke Yao, et al.. (2016). Phosphorylated Codonopsis pilosula polysaccharide could inhibit the virulence of duck hepatitis A virus compared with Codonopsis pilosula polysaccharide. International Journal of Biological Macromolecules. 94(Pt A). 28–35. 62 indexed citations
18.
Yao, Fangke, Yun Chen, Ke Ming, et al.. (2016). Replication cycle of duck hepatitis A virus type 1 in duck embryonic hepatocytes. Virology. 491. 73–78. 14 indexed citations
19.
Chen, Yun, Ling Zeng, Wen Xiong, et al.. (2015). Anti-duck virus hepatitis mechanisms of Bush Sophora Root polysaccharide and its sulfate verified by intervention experiments. Virus Research. 204. 58–67. 8 indexed citations
20.
Chen, Yun, Yixuan Wang, Wen Xiong, et al.. (2014). The anti-DHAV activities of Astragalus polysaccharide and its sulfate compared with those of BSRPS and its sulfate. Carbohydrate Polymers. 117. 339–345. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026